EAU 2025

Bladder Cancer Controversies: Rapid-Fire Debates from EAU26Sent on 01 April 2026

Targeting DNA Repair Pathways in Prostate Cancer EAU 2026Sent on 16 March 2026

Data Shaping Care in Renal and Upper Tract Cancers from EAU 2026Sent on 16 March 2026

EAU 2026 PSMA-Guided Therapy and New Intensification Strategies in Prostate CancerSent on 15 March 2026

EAU 2026 Where Bladder Cancer Treatment Is Heading NextSent on 15 March 2026

EAU 2026: Surgery and Intravesical Therapy in NMIBCSent on 14 March 2026

EAU 2026: Bladder Sparing Treatment in Non-Muscle Invasive Bladder CancerSent on 14 March 2026

EAU 2026 Evidence Shaping Prostate Cancer Screening, Imaging and TreatmentSent on 13 March 2026

2026 European Association of Urology (EAU) Annual Meeting: Management of Oligometastatic Prostate Cancer: Not as Easy as It SeemsSent on 13 March 2026

SUO 2025 Bladder-Sparing Innovation in High-Risk NMIBCSent on 06 December 2025

ESMO 2025: SunRISe-4 Results and Highlights Across MIBC and mUCSent on 21 October 2025

ESMO 2025: Trial Results from ENZARAD - PRESTO - EMBARK - CAPItello-281 - PSMAAddition Sent on 21 October 2025

Advances in Imaging Based Theranostics from ESMO 2025 Sent on 19 October 2025

ESMO 2025: Renal Cell Carcinoma Focused on New Data Supporting Evolving Treatment Strategies Sent on 19 October 2025

ESMO 2025: Enfortumab Vedotin + Pembrolizumab Drives Survival Gains in MIBCSent on 19 October 2025

ESMO 2025: Radioligand and Combination Strategies in Prostate CancerSent on 18 October 2025

ESMO 2025 Trials Shaping What’s Next in Renal & Urothelial CancerSent on 18 October 2025

ESMO 2025: Advancing Care in Metastatic Prostate Cancer and BeyondSent on 18 October 2025

European Society for Medical Oncology (ESMO) 2025: Defining New Standards in Urothelial Cancer CareSent on 17 October 2025

Emerging Strategies for NMIBC: EAU 2025 Bladder CancerSent on 26 March 2025

EAU 2025 - Navigating Prostate Cancer: Clinical Decisions from Diagnosis to Disease ProgressionSent on 25 March 2025

Advancing Care in Bladder & UTUC: Takeaways from EAU 2025Sent on 24 March 2025

Emerging Evidence in Advanced Prostate Cancer Care from the European Association of Urology (EAU) 2025 Sent on 23 March 2025

European Association of Urology (EAU) 2025: Biomarkers & Organ Sparing: Evolving Paradigms in Uro-OncologySent on 23 March 2025

European Association of Urology (EAU) 2025 Hormone-Sensitive Prostate Cancer Management and Evolving Peri-Operative StrategiesSent on 22 March 2025

European Association of Urology (EAU) 2025 What’s Shaping Bladder Cancer Care: Debates, Data & the FutureSent on 21 March 2025

Coverage of the 2025 European Association of Urology (EAU) Congress Starts FridaySent on 19 March 2025

Display #
Results 1 - 27 out of 27